TrialTrials2022

Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial.

Thomas Zeyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.